Literature DB >> 2500425

Seizures and bupropion: a review.

J Davidson1.   

Abstract

The relationship between seizure occurrence and use of bupropion was examined on the basis of manufacturer's reports. The observed incidence of seizures with bupropion doses of 450 mg/day or less ranged from 0.35%-0.44%, depending on the method of calculation. The cumulative 2-year risk of seizures in patients receiving the maximum recommended dose of 450 mg/day or less was 0.48%. The risk of seizure appears to be higher with bupropion doses above the recommended maximum, and predisposing factors were noted in over half of the 37 reported cases. Possible risk factors are presented and recommendations are given for the use of bupropion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500425

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  30 in total

Review 1.  Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice.

Authors:  M J Burke; S H Preskorn
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

Review 2.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

3.  Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified release products: workshop summary report.

Authors:  Mei-Ling Chen; Vinod P Shah; Derek Ganes; Kamal K Midha; James Caro; Prabu Nambiar; Mario L Rocci; Avinash G Thombre; Bertil Abrahamsson; Dale Conner; Barbara Davit; Paul Fackler; Colm Farrell; Suneel Gupta; Russell Katz; Mehul Mehta; Sheldon H Preskorn; Gerard Sanderink; Salomon Stavchansky; Robert Temple; Yaning Wang; Helen Winkle; Lawrence Yu
Journal:  AAPS J       Date:  2010-05-04       Impact factor: 4.009

Review 4.  Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Authors:  Linda P Dwoskin; Anthony S Rauhut; Kelley A King-Pospisil; Michael T Bardo
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

5.  A case report of seizure induced by bupropion nasal insufflation.

Authors:  Stanley Hill; Harminder Sikand; Jonathan Lee
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 6.  Pharmacological treatment of anxiety disorders: current treatments and future directions.

Authors:  Frank J Farach; Larry D Pruitt; Janie J Jun; Alissa B Jerud; Lori A Zoellner; Peter P Roy-Byrne
Journal:  J Anxiety Disord       Date:  2012-08-15

Review 7.  Drug therapy for geriatric depression.

Authors:  R Bressler; M D Katz
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

Review 8.  Treatment considerations for the depressed geriatric medical patient.

Authors:  H G Koenig
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

Review 9.  Antidepressant toxicity and the need for identification and concentration monitoring in overdose.

Authors:  B M Power; L P Hackett; L J Dusci; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

Review 10.  Drug-induced seizures in the elderly. Causative agents and optimal management.

Authors:  K L Franson; D P Hay; V Neppe; W Y Dahdal; W U Mirza; G T Grossberg; D M Chatel; P A Szwabo; S Kotegal
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.